Evidence map›Paper›PMID 39478289›Full record

ArticleACS applied materials & interfaces2024

Enhancing Antibacterial Properties of Titanium Implants through Covalent Conjugation of Self-Assembling Fmoc-Phe-Phe Dipeptide on Titania Nanotubes.

Ramesh Singh, Ketul C Popat

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Fabrication of TiOMicromachines · 2026
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ramesh SinghDepartment of Bioengineering, College of Engineering and Computing, George Mason University, Fairfax, Virginia 22030, United States.ORCID 0000-0002-2874-4971
Ketul C PopatDepartment of Bioengineering, College of Engineering and Computing, George Mason University, Fairfax, Virginia 22030, United States.ORCID 0000-0002-2417-7789

Funding

Nanostructured Surfaces With Improved HemocompatibilityR21EB033511 · NIBIB · GEORGE MASON UNIVERSITY · PI KIPPER, MATTHEW, POPAT, KETUL CHANDRAKANT · 2022 to 2023
$410k
NIBIB NIH HHS R21 EB033511
6 · The paper itself

Abstract

Bacterial infections and biofilm formation are significant challenges for medical implants. While titanium nanotube engineering improves biocompatibility, it cannot prevent bacterial adhesion and biofilm formation. Optimizing the biomaterial's surface chemistry is vital for its desired functioning in the biological environment. This study demonstrates the covalent conjugating of the self-assembling dipeptide N-fluorenylmethyloxycarbonyl-diphenylalanine (Fmoc-FF) onto titanium nanotube surfaces (TiNTs) without altering the topography. Fmoc-FF peptides, in conjugation with TiNTs, can inhibit biofilm formation, eradicate pre-existing biofilms, and kill bacteria. This functionalization imparts antibacterial properties to the surface while retaining beneficial nanotube topography, synergistically enhancing bioactivity. Surface characterization by XPS, FT-IR, EDS, and SEM confirmed the successful functionalization. Bacterial adhesion experiments showed a significantly improved antibacterial activity of the functionalized TiNT surfaces. This study opens future possibilities for associating biomedical applications such as cell-cell interactions, tissue engineering, and controlled drug delivery of multifunctional self-assembling short peptides with implant materials through surface functionalization.

Indexed as

Anti-Bacterial AgentsBiofilmsDipeptidesNanotubesTitaniumBacterial AdhesionFluorenesProstheses and ImplantsStaphylococcus aureusSurface PropertiesAnti-Bacterial AgentsDipeptidesFluorenesTitaniumtitanium dioxideAntibacterial surfaceBacterial adhesionBiofilm formationBiomedical implantsFmoc-FF dipeptideTitania nanotubes

Identifiers

PMID39478289
PMCPMC11565481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.